Yasuko Yuasa
About
In The Last Decade
Yasuko Yuasa
17 papers receiving 332 citations
Peers
Comparison fields: 5 of 63
- Nephrology 214
- Surgery 73
- Emergency Medical Services 63
- Clinical Biochemistry 62
- Endocrinology, Diabetes and Metabolism 54
Countries citing papers authored by Yasuko Yuasa
This map shows the geographic impact of Yasuko Yuasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuko Yuasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuko Yuasa more than expected).
Fields of papers citing papers by Yasuko Yuasa
This network shows the impact of papers produced by Yasuko Yuasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuko Yuasa. The network helps show where Yasuko Yuasa may publish in the future.
Co-authorship network of co-authors of Yasuko Yuasa
This figure shows the co-authorship network connecting the top 25 collaborators of Yasuko Yuasa. A scholar is included among the top collaborators of Yasuko Yuasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuko Yuasa. Yasuko Yuasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 18 | |
| 3 | [Serum calcium levels at first renal replacement therapy and patients survival]. | 1 |
| 4 | 2 | |
| 5 | 34 | |
| 6 | 17 | |
| 7 | 16 | |
| 8 | 172 | |
| 9 | 28 | |
| 10 | 0 | |
| 11 | [Clinical significance of urinary methylguanidine in non-dialyzed patients with chronic renal failure--prediction of progression rate of renal dysfunction]. | 1 |
| 12 | 1 | |
| 13 | 2 | |
| 14 | 0 | |
| 15 | Cefotetan (YM09330) に関する臨床的研究 | 1 |
| 16 | 1 | |
| 17 | 12 | |
| 18 | 3 | |
| 19 | 4 | |
| 20 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.